<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
    xmlns:content="http://purl.org/rss/1.0/modules/content/"
    xmlns:media="http://search.yahoo.com/mrss/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title><![CDATA[Health – AI Global News]]></title>
        <link>https://www.healthbiz.in/rss/category/health</link>
        <atom:link href="https://www.healthbiz.in/rss/category/health" rel="self" type="application/rss+xml" />
        <description><![CDATA[Latest Health news from AI Global News. ]]></description>
        <language>en-us</language>
        <pubDate>Tue, 17 Nov 2026 13:33:02 +0000</pubDate>
        <lastBuildDate>Tue, 17 Nov 2026 13:33:02 +0000</lastBuildDate>
        <managingEditor>editor@aiglobalnews.com (AI Global News)</managingEditor>
        <webMaster>webmaster@aiglobalnews.com</webMaster>
        <category><![CDATA[Health]]></category>
        <ttl>60</ttl>

        
                    <item>
                <title><![CDATA[Healthcare GCC Jobs 2026 Surge to 67,000 Openings]]></title>
                <link>https://www.healthbiz.in/healthcare-gcc-jobs-2026-surge-to-67000-openings-6adc4de9c3379</link>
                <guid isPermaLink="true">https://www.healthbiz.in/healthcare-gcc-jobs-2026-surge-to-67000-openings-6adc4de9c3379</guid>
                <description><![CDATA[The loudest hiring story in Indian healthcare right now has nothing to do with doctors. It is happening in the air-conditioned offices behind the hospital — the...]]></description>
                <content:encoded><![CDATA[<p>The loudest hiring story in Indian healthcare right now has nothing to do with doctors. It is happening in the air-conditioned offices behind the hospital &mdash; the global capability centres that process claims, manage clinical data and run compliance for overseas health systems. And the people those offices want most are not the ones fresh off campus.</p>
<p>Quess Corp's India Healthcare GCC Outlook 2026 projects roughly 67,000 job openings in the sector in 2026. Nearly 93 per cent of that demand, according to the report, is concentrated among professionals with 3 to 12 years of experience.</p>
<h2>Sixty-Seven Thousand Jobs &mdash; and a Very Narrow Target</h2>
<p>The headline number sounds expansive. The detail underneath is not. If almost all of the demand sits inside a single experience band, then the market for a healthcare GCC role in 2026 is essentially a market for people who have already done the job somewhere else.</p>
<p>The report describes this as a growing preference for specialised, mid-career talent &mdash; professionals who arrive knowing the workflow, the terminology and the compliance boundaries rather than needing months to learn them.</p>
<h2>Why Experience Is Being Bought, Not Built</h2>
<p>Healthcare capability centre work is unforgiving of amateur error. Teams typically handle insurance claims adjudication, prior authorisation, medical coding, clinical data management, pharmacovigilance and regulatory reporting for parent organisations abroad.</p>
<p>A mistake in a coding file or a missed compliance step does not stay internal. It can trigger a denied claim, an audit finding or a regulatory flag. That asymmetry &mdash; small errors, large consequences &mdash; is a plausible explanation for why hiring managers would rather pay a premium for someone who has already absorbed the risk once.</p>
<h2>How Healthcare Became a GCC Frontier</h2>
<p>India's capability centre industry began with IT services and moved through banking, finance and analytics. Healthcare was a later entrant, largely because the work is regulated, data-sensitive and often tied to patient safety.</p>
<p>Over time, that caution became a selling point. Once global health insurers and providers built confidence in offshore teams handling sensitive workflows, the scope expanded from transactional processing into coding, analytics and clinical support.</p>
<h2>Who Gains &mdash; and Who Is Left Standing Outside</h2>
<p>For a professional with five years in medical coding or three years in claims operations, this is a favourable market. Demand is concentrated exactly where they sit, and a 3&ndash;12 year band is wide enough to cover a range of salary expectations.</p>
<p>The picture is less comfortable elsewhere. Freshers face a thin sliver of the 7 per cent of demand that falls outside the mid-career band. Career switchers without healthcare domain exposure, and professionals returning from long breaks, also enter at a structural disadvantage.</p>
<h2>What Quess Corp Actually Says &mdash; and What It Doesn't</h2>
<p>According to the report, the sector is projected to generate about 67,000 openings in 2026, with the overwhelming majority of demand tied to professionals in the 3&ndash;12 year bracket. The framing is consistent with what staffing firms have been observing across India's capability centre market more broadly.</p>
<p>What the report does not appear to break down, based on the available summary, is role-level detail, city-level distribution or the split between new positions and replacement hiring. Those gaps matter for anyone building a job strategy on the back of one forecast.</p>
<h2>How to Read the 93 Per Cent Correctly</h2>
<p>The figure describes the expected distribution of demand, not a guarantee about who will ultimately be hired. It is a forecast, and forecasts in staffing are notoriously sensitive to client budgets and global healthcare spending cycles.</p>
<p>It is also worth noting that 3 to 12 years is an unusually wide band. It stretches from a junior analyst to a team lead, which means the competition inside that group is still fierce and differentiated by specialisation rather than seniority alone.</p>
<h2>Confirmed Facts vs Open Questions</h2>
<p><strong>Confirmed:</strong> Quess Corp published an India Healthcare GCC Outlook 2026 report; it projects around 67,000 job openings for the sector in 2026; and nearly 93 per cent of that demand is attributed to professionals with 3&ndash;12 years of experience.</p>
<p><strong>Unclear:</strong> which specific functions will absorb the largest share of hiring, whether the 67,000 figure counts new roles or replacement demand, and how much of it is already committed rather than aspirational. Any projection about 2026 should be read as an estimate until quarterly hiring data lands.</p>
<h2>The Moat: Why Healthcare GCC Work Is Hard to Relocate</h2>
<p>Healthcare capability centres are sticky in a way that customer support lines are not. The work sits inside regulated workflows, requires familiarity with payer and provider systems, and accumulates institutional knowledge that clients are reluctant to rebuild elsewhere.</p>
<p>That stickiness protects existing Indian GCCs from being casually shifted to another geography. It also explains the hiring pattern: if you cannot move the work easily, you invest in the people doing it &mdash; which means paying for proven experience rather than running a large trainee pipeline.</p>
<h2>The Risk in a Mid-Career-Only Model</h2>
<p>There is a cost to hiring almost exclusively in the middle. Wage inflation in the 3&ndash;12 year bracket is one obvious risk when several GCCs chase the same profile in the same cities.</p>
<p>Attrition is another. Mid-career professionals are the most mobile segment of the workforce, and a market built on lateral hiring can become a market built on poaching. The longer-term concern is a thinning leadership pipeline &mdash; organisations that never train juniors eventually run short of people ready to step up.</p>
<h2>The Wider Pattern: India's Job Market Is Tilting Toward Experience</h2>
<p>Healthcare is not an isolated case. Across capability centres, employers have been steadily raising the experience bar for entry-level roles as automation and AI tools absorb routine tasks.</p>
<p>The result is a peculiar squeeze: headline job creation remains strong, but the on-ramp for first-time job seekers narrows. Forecasts like this one are a useful reminder that "jobs created" and "jobs accessible to freshers" are not the same number.</p>
<h2>If You're Job Hunting in 2026, Here's the Practical Playbook</h2>
<p>Lead with specialisation, not years. A candidate who can name the exact payer systems, coding standards or compliance frameworks they have worked with reads very differently from one who lists five years of "healthcare operations".</p>
<p>For those outside the 3&ndash;12 band, the realistic route is adjacency. Freshers can target certification-backed entry roles in medical coding or pharmacovigilance support; career switchers can lean on transferable process or analytics skills while closing the domain gap deliberately.</p>
<p>And for anyone already in the band, the advantage is temporary. The same forecast that makes mid-career talent scarce in 2026 is an invitation for thousands of others to enter that bracket by 2027.</p>
<h2>What to Watch Next</h2>
<p>Three signals will show whether this forecast holds: quarterly headcount disclosures from major healthcare capability centres, the trajectory of salary bands for 4&ndash;8 year professionals in coding and claims, and whether firms reintroduce structured fresher training programmes.</p>
<p>If hiring stays this concentrated through the year, expect the conversation to shift from "how many jobs" to "who is being shut out" &mdash; a debate India's workforce policy has not yet had at scale.</p>
<h2>Our Take</h2>
<p>A 67,000-job forecast is good news for the sector and a genuinely strong signal for experienced healthcare professionals. But the striking part of this report is not the volume &mdash; it is the shape.</p>
<p>An industry that hires almost entirely in the middle is an industry borrowing capability from elsewhere rather than growing it. That works while the supply of trained mid-career talent lasts. The question worth asking is what happens when it doesn't.</p>
<h2>Frequently Asked Questions</h2>
<h3>How many jobs will healthcare GCCs create in 2026?</h3>
<p>Quess Corp's India Healthcare GCC Outlook 2026 projects around 67,000 job openings in the sector for 2026. This is a forecast based on current hiring trends, not a confirmed hiring commitment from individual companies.</p>
<h3>Why are healthcare GCCs hiring mainly mid-career professionals?</h3>
<p>Because the work is compliance-heavy and error-sensitive. Employers prefer candidates with 3&ndash;12 years of experience who already understand claims, coding, clinical data or regulatory workflows, rather than spending months training that knowledge from scratch.</p>
<h3>Does this mean freshers have no chance in healthcare GCCs?</h3>
<p>Not zero &mdash; but the opportunity is narrow. With nearly 93 per cent of demand concentrated in the 3&ndash;12 year band, entry-level roles make up a small share. Freshers improve their odds through certified, skill-specific qualifications in areas like medical coding or pharmacovigilance.</p>
<h3>Which skills matter most for these roles?</h3>
<p>Domain-specific knowledge carries the most weight: medical coding standards, claims adjudication and revenue cycle processes, clinical data management, pharmacovigilance and regulatory reporting. Familiarity with the compliance expectations of US or UK health systems is an added advantage.</p>]]></content:encoded>
                <dc:creator><![CDATA[AI Global]]></dc:creator>
                <pubDate>Sat, 24 Oct 2026 06:16:56 +0000</pubDate>

                                    <media:content url="/storage/media/images/1792844167_135159928_article.webp" medium="image">
                        <media:title type="html"><![CDATA[Healthcare GCC Jobs 2026 Surge to 67,000 Openings]]></media:title>
                    </media:content>
                    <enclosure url="/storage/media/images/1792844167_135159928_article.webp" length="0" type="image/jpeg" />
                
                                    <category><![CDATA[Health]]></category>
                            </item>
                    <item>
                <title><![CDATA[Rare disease funding crisis sparks PM Modi appeal]]></title>
                <link>https://www.healthbiz.in/rare-disease-funding-crisis-sparks-pm-modi-appeal-6ad644a6b5aec</link>
                <guid isPermaLink="true">https://www.healthbiz.in/rare-disease-funding-crisis-sparks-pm-modi-appeal-6ad644a6b5aec</guid>
                <description><![CDATA[For families managing a rare disease in India, the treatment calendar is rarely decided by the doctor. It is decided by how long the money lasts. This week, tha...]]></description>
                <content:encoded><![CDATA[<p>For families managing a rare disease in India, the treatment calendar is rarely decided by the doctor. It is decided by how long the money lasts. This week, that arithmetic turned into a direct appeal to the Prime Minister.</p>
<p>LSDSS, a patient support organisation working on lysosomal storage disorders, said patients with progressive, potentially life-threatening conditions are seeing their treatment disrupted after exhausting the financial assistance sanctioned for them. The group has asked Prime Minister Narendra Modi to intervene and release additional funds.</p>
<h2>An appeal that begins where the paperwork ends</h2>
<p>The request is not about a new drug or a new trial. It is about continuity &mdash; the simple, brutal question of whether the next dose can be paid for.</p>
<p>According to LSDSS, several patients have already used up the sanctioned support available to them under existing mechanisms. Once that ceiling is reached, treatment does not pause politely. Enzyme replacement and other therapies for these conditions are typically lifelong, and stopping them can mean irreversible progression.</p>
<h2>What "sanctioned assistance exhausted" looks like in a hospital ward</h2>
<p>For a rare disease, the funding is finite and the disease is not. Assistance is typically approved for an eligible case up to a defined limit; the therapy itself continues month after month, in many cases for the rest of a patient's life.</p>
<p>That mismatch is where families get trapped. The file closes. The prescription does not.</p>
<h2>How India's rare disease funding is structured &mdash; and where it pinches</h2>
<p>Support in India runs through the National Policy for Rare Diseases, 2021, which channels treatment funding via designated Centres of Excellence and provides for financial assistance of up to ₹50 lakh per patient in eligible cases, as per the policy framework.</p>
<p>That design gives patients a defined ceiling rather than an open-ended commitment. For short-term interventions that works. For lifelong enzyme therapy, it creates a predictable cliff edge &mdash; one that patients reach at different times, often with little warning.</p>
<h2>The families carrying a bill no household can absorb</h2>
<p>Rare disease care in India is overwhelmingly private spending. Imported biologics, cold-chain logistics and repeat infusions put annual costs far beyond ordinary household income.</p>
<p>When institutional support ends, the burden does not disappear. It moves to savings, property, extended family and, in many cases, stopped treatment. The people most affected are usually children diagnosed in the first years of life.</p>
<h2>What LSDSS is asking for &mdash; and what it has not disclosed</h2>
<p>The organisation's demand, as stated, is for the Prime Minister's intervention to secure additional funds so that treatment does not lapse. It has not, in the information available, publicly specified the exact amount sought or the number of patients currently affected.</p>
<p>That absence of detail is worth noting. It does not weaken the appeal, but it means the scale of the immediate gap cannot yet be independently verified.</p>
<h2>Why rare disease medicine is expensive by design</h2>
<p>Rare disease therapies are priced against very small patient populations. Research, trials and manufacturing costs are recovered from a few thousand &mdash; sometimes a few hundred &mdash; patients worldwide.</p>
<p>India adds another layer: most of these drugs are imported, which brings currency costs, duties and distribution margins into the bill. Unlike mass-market medicines, there is no volume discount waiting at the end of the pipeline.</p>
<h2>Confirmed facts, and the questions still open</h2>
<p><strong>Confirmed:</strong> LSDSS has approached the Prime Minister seeking additional funds; the organisation states that patients have exhausted sanctioned assistance and are facing treatment interruptions; support in India is delivered through the National Policy for Rare Diseases framework.</p>
<p><strong>Unclear:</strong> How many patients are currently affected, how much additional funding has been requested, whether any interim relief has been sanctioned, and what the Prime Minister's Office or Health Ministry position is. Any speculation on these points should be treated as speculation.</p>
<h2>The clinical risk of stop-start treatment</h2>
<p>In lysosomal storage disorders, enzyme replacement therapy works only while it is given. Interruptions are not neutral downtime.</p>
<p>Treating clinicians have long cautioned that gaps in therapy can allow disease progression to resume &mdash; affecting mobility, organ function, cognition in some conditions, and overall life expectancy. Restarting later is not the same as never stopping.</p>
<h2>A pattern that keeps repeating in rare disease care</h2>
<p>This is not an isolated administrative hiccup. It is the predictable outcome of a fixed grant meeting an unfixed need.</p>
<p>India's rare disease conversation has moved from "no policy" to "a policy with limits." The next debate is harder and more expensive: should support for a lifelong condition be structured as one-time assistance, or as continuing care?</p>
<h2>If you or your child is affected: practical steps</h2>
<p>Families facing a funding lapse should approach the Centre of Excellence where treatment is registered, since sanctions and extensions are routed through these institutions under the policy framework.</p>
<p>Keep a documented file &mdash; diagnosis, treating specialist's prescription, cost estimate and proof of previous sanction. Raising the case through a recognised patient organisation and, where relevant, the state health department, creates a paper trail that administrative reviews require.</p>
<h2>What happens next</h2>
<p>The decision rests with the Union Health Ministry and the Centres of Excellence that administer the funds. An intervention from the Prime Minister's Office could take the form of additional allocation, an interim release, or a case-by-case review &mdash; but none of these has been confirmed.</p>
<p>For now, the appeal exists. The invoices continue to arrive.</p>
<h2>Our Take</h2>
<p>The story here is not one organisation's letter. It is the design flaw the letter exposes: India built a rare disease policy around a ceiling, while the conditions it covers have no ceiling at all.</p>
<p>Until funding is structured around continuity of care rather than a one-time sanction, appeals to the highest office will keep recurring &mdash; and patients will keep measuring their lives in approved amounts rather than in years.</p>
<h2>Frequently Asked Questions</h2>
<h3>Who has approached the Prime Minister over rare disease funding?</h3>
<p>LSDSS, a patient support organisation focused on lysosomal storage disorders, has sought Prime Minister Narendra Modi's intervention to secure additional funds for patients whose sanctioned financial assistance has been exhausted.</p>
<h3>Why is the treatment being interrupted?</h3>
<p>Because the financial assistance approved for eligible patients has a defined limit, while therapies for these progressive conditions are usually lifelong. Once the sanctioned amount is used, families must fund treatment themselves or stop.</p>
<h3>How does India fund rare disease treatment?</h3>
<p>Through the National Policy for Rare Diseases, 2021, which routes support via designated Centres of Excellence and provides for financial assistance of up to ₹50 lakh per patient in eligible cases under the policy framework.</p>
<h3>Has the government responded to the appeal?</h3>
<p>No public statement from the Prime Minister's Office or the Union Health Ministry was available at the time of writing. The quantum of additional funding requested has also not been publicly specified.</p>]]></content:encoded>
                <dc:creator><![CDATA[AI Global]]></dc:creator>
                <pubDate>Mon, 19 Oct 2026 16:23:43 +0000</pubDate>

                                    <media:content url="/storage/media/images/1792497562_images-13_article.webp" medium="image">
                        <media:title type="html"><![CDATA[Rare disease funding crisis sparks PM Modi appeal]]></media:title>
                    </media:content>
                    <enclosure url="/storage/media/images/1792497562_images-13_article.webp" length="0" type="image/jpeg" />
                
                                    <category><![CDATA[Health]]></category>
                            </item>
                    <item>
                <title><![CDATA[NMC Remote Authentication Medical Records Explained]]></title>
                <link>https://www.healthbiz.in/nmc-remote-authentication-medical-records-explained-6ad5f04c8bbfd</link>
                <guid isPermaLink="true">https://www.healthbiz.in/nmc-remote-authentication-medical-records-explained-6ad5f04c8bbfd</guid>
                <description><![CDATA[For a patient in a district town with a complicated heart condition or a stubborn neurological symptom, the hardest part is rarely the medicine. It is the wait...]]></description>
                <content:encoded><![CDATA[<p>For a patient in a district town with a complicated heart condition or a stubborn neurological symptom, the hardest part is rarely the medicine. It is the wait &mdash; for a specialist who may sit three hundred kilometres away, in a city where the appointment itself requires a day off work and a train ticket.</p>
<p>That is the gap the National Medical Commission's move on remote authentication of medical records is being measured against. On Wednesday, healthcare industry body Nathealth came out in support of the decision, calling it a significant step towards strengthening digital health and widening access to quality care.</p>
<h2>What the NMC Decision Actually Changes</h2>
<p>At its core, the move concerns authentication &mdash; the formal act by which a medical record is verified, signed off and made clinically valid. Doing this remotely means the professional certifying a record does not necessarily have to be physically present where the record was generated.</p>
<p>The distinction sounds procedural. In practice, it is the hinge on which digital care turns. A record that cannot be authenticated at a distance cannot easily travel &mdash; between a primary health centre and a district hospital, between a general physician and a super-specialist, or between a rural patient and a metro consultant reviewing a scan at 11 p.m.</p>
<h2>Nathealth's Argument: Distance Shouldn't Decide Quality of Care</h2>
<p>Nathealth's reasoning is straightforward. If records can be authenticated remotely, specialist judgement can reach places where specialists are not physically posted &mdash; smaller towns, hill districts, and interiors where a single physician may cover several facilities.</p>
<p>The body described the decision as a meaningful advance for digital health in the country and for accessibility of quality healthcare, especially in areas where specialist density is thin. It is a position that aligns the private hospital ecosystem with the regulator's broader digital push.</p>
<h2>How India's Digital Health Architecture Reached This Point</h2>
<p>This did not arrive in isolation. India has spent the better part of a decade building the plumbing for digital care &mdash; the Ayushman Bharat Digital Mission, health IDs, linked records, and telemedicine practice frameworks that were stress-tested during the pandemic and never fully rolled back.</p>
<p>Each layer solved one problem and exposed the next. Portability raised questions of consent. Teleconsultation raised questions of liability. Electronic records raised the most awkward question of all: who, exactly, signs off on a record, and from where? The NMC's move is best read as an attempt to answer that last question.</p>
<h2>Who Stands to Gain &mdash; and Who Is Still Waiting</h2>
<p>The clearest beneficiaries are patients outside metro cities, particularly those with conditions that need specialist interpretation rather than specialist presence &mdash; follow-up reviews, second opinions, chronic disease monitoring, imaging interpretation.</p>
<p>Hospital administrators in tier-2 and tier-3 cities stand to gain too. A facility that can route records to a remote certifier does not have to structure its entire clinical roster around who is credentialed to sign.</p>
<p>Less clear is the position of smaller standalone clinics and single-doctor practices, which may find compliance and technology costs harder to absorb than large hospital chains. Access has a cost side, and it rarely lands evenly.</p>
<h2>Why Regulators Care About Who Signs Off on a Record</h2>
<p>Authentication is not a bureaucratic ritual. It is the point at which a clinical opinion becomes an accountable document &mdash; the basis for a prescription, a diagnosis, a claim, or a legal defence.</p>
<p>Loosen that link carelessly and the risks are real: records certified by professionals with no genuine involvement in the case, prescriptions authenticated without proper examination, and ambiguity over who answers when something goes wrong. Regulators are judged on those failures far more than on the conveniences they enable, which is why the design of the safeguard matters as much as the principle.</p>
<h2>Why Nathealth's Endorsement Carries Weight in Policy Circles</h2>
<p>Nathealth functions as an umbrella voice for a large section of India's private hospital and healthcare provider ecosystem. When it endorses a regulatory direction, it signals that the operational machinery &mdash; the IT systems, clinical governance structures and compliance teams inside hospitals &mdash; is likely to be pointed the same way.</p>
<p>That matters in a system where private providers carry a substantial share of outpatient and inpatient care. A policy that hospitals treat as workable tends to get implemented; one they treat as paperwork tends to get worked around.</p>
<h2>Confirmed Facts vs What Remains Unclear</h2>
<p><strong>Confirmed:</strong> The NMC has moved on remote authentication of medical records. Nathealth has publicly backed that move and described it as significant for digital health and access to quality care in underserved areas.</p>
<p><strong>Unclear:</strong> The precise operational scope of the change &mdash; which categories of records are covered, what constitutes valid remote authentication, the technology or identity standards required, and the implementation timeline. These details were not part of the stated position, and this report does not speculate on them.</p>
<h2>The Risks Nobody Should Wave Away</h2>
<p>Three concerns deserve early attention. First, verification integrity: remote authentication must establish, beyond doubt, that the professional certifying a record is who they claim to be and has actually reviewed the material.</p>
<p>Second, accountability. If a remotely authenticated record is later contested in a clinical negligence claim, the chain of responsibility must be traceable &mdash; regulator, hospital, and certifying doctor each clear on their role.</p>
<p>Third, the digital divide. In districts with patchy connectivity and limited device access, a policy designed to narrow inequality in care could, if implemented carelessly, reproduce it in digital form.</p>
<h2>A Pattern Beyond One Circular</h2>
<p>This fits a wider global shift: health systems everywhere are separating where care is delivered from where clinical judgement is exercised. Radiology reading, pathology interpretation and specialist consultation have already crossed that line.</p>
<p>What is different in India is the scale and the stakes. When a country's specialist concentration is heavily urban, the ability to authenticate a record remotely stops being a convenience and becomes an equity instrument &mdash; or a missed opportunity.</p>
<h2>What Patients, Doctors and Hospital Administrators Should Watch</h2>
<p>Patients should watch for clarity on consent &mdash; specifically, whether they will be told when a record is authenticated remotely and by whom. Doctors should watch for the standards governing identity verification and clinical review obligations. Hospitals should watch for technical specifications, since compliance costs will fall unevenly on large chains and standalone facilities.</p>
<p>The single most useful indicator, though, is the implementing guidance. Principles are rarely the problem; detail usually is.</p>
<h2>What Comes Next</h2>
<p>The immediate next step is expected to be operational clarity from the regulator and the spread of that clarity through hospital systems. If the framework lands with clear standards, the sector's support &mdash; already visible &mdash; is likely to translate into adoption reasonably quickly.</p>
<p>If it lands ambiguously, expect a familiar pattern: early enthusiasm, uneven implementation, and then a corrective circular. None of this is unusual for digital health reform, and none of it should be read as a verdict on the policy's intent.</p>
<h2>Our Take</h2>
<p>The headline here is a statement of support, not a completed reform. That distinction matters, because endorsements are cheap and implementation is not.</p>
<p>Still, there is real substance in what Nathealth has said. India's digital health stack has matured to the point where the binding constraint is no longer infrastructure but governance &mdash; who is allowed to certify what, from where, and with what accountability. The NMC's move engages that question directly. The sector's backing suggests the answer is unlikely to be resisted by the institutions that must live with it.</p>
<p>For a patient in a small town, none of this is abstract. Every layer of friction between them and a specialist's judgement &mdash; including a signature that has to travel further than the patient can &mdash; is a delay measured in weeks of a treatable illness.</p>
<h2>Frequently Asked Questions</h2>
<h3>What is remote authentication of medical records?</h3>
<p>It refers to the process of verifying and formally signing off on a medical record without the certifying professional having to be physically present where the record was created. It allows clinical verification to happen at a distance, typically through digital systems.</p>
<h3>Why has Nathealth supported the NMC move?</h3>
<p>Nathealth has described the decision as a significant step for digital health in India and for making quality healthcare more accessible, particularly in smaller towns and remote areas where specialists are fewer in number.</p>
<h3>Does this mean patients can consult doctors anywhere in India now?</h3>
<p>Not automatically. The move concerns authentication of medical records, which is one component of digital care. Consultation, consent, liability and prescription rules are governed by separate frameworks, and the detailed scope of this change has not been fully spelled out publicly.</p>
<h3>What should patients and hospitals watch for next?</h3>
<p>The implementing guidelines &mdash; covering identity verification, which records are covered, technical standards, and how responsibility is assigned if a record is disputed. Those details will determine whether the change improves access in practice or mostly adds paperwork.</p>]]></content:encoded>
                <dc:creator><![CDATA[AI Global]]></dc:creator>
                <pubDate>Mon, 19 Oct 2026 10:23:44 +0000</pubDate>

                                    <media:content url="/storage/media/images/1792497654_hospitals-body-backs-nmc-move-on-remote-authentication-of-medical-records_article.webp" medium="image">
                        <media:title type="html"><![CDATA[NMC Remote Authentication Medical Records Explained]]></media:title>
                    </media:content>
                    <enclosure url="/storage/media/images/1792497654_hospitals-body-backs-nmc-move-on-remote-authentication-of-medical-records_article.webp" length="0" type="image/jpeg" />
                
                                    <category><![CDATA[Health]]></category>
                            </item>
            </channel>
</rss>